Stage IB-IIB Cutaneous T-Cell Lymphoma
1 clinical trials · Condition
◉ Watch Stage IB-IIB Cutaneous T-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma (NCT04128072) | European Organisation for Research and Treatment of Cancer - EORTC | 2023-03-07 |
Track Stage IB-IIB Cutaneous T-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.